KIR2DS4

killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.

☰ Filters

Products

Proteins (2)

Type

Recombinant (2)

Target

KIR2DS4 (2)

Publications

No (2)

Tag

His (1)

Species

Human (2)

Source

E. coli (2)

Select

Human KIR2DS4 Protein (Recombinant) - LS-G3484

Source:

E. coli

Tag:

None

Price:

100 µg/$411; 500 µg/$985; 20 µg/$276

Select

Human KIR2DS4 Protein (Recombinant His) (aa22-302) - LS-G13994

Source:

E. coli

Tag:

His

Molecular Weight:

32.1 kDa

Price:

10 µg/$266; 50 µg/$350; 100 µg/$557; 200 µg/$697; 1 mg/$1,716; 500 µg/$1,291; 5 mg/$2,666; 2 mg/$1,893

Viewing 1-2 of 2 product results

(0) Selected Add Selected To Cart Compare Selected Email Selected Clear Selected Top Of Search

---

Filtered By:

Products: Proteins

Clear Filters

If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.